Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PDE6D | O43924 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22945598 | 0.90 | ALOX5 (0.35) | L3MBTL1KDM4EALDH1A1HPGDLMNA | |
| SCHEMBL21515429 | 0.89 | ALDH1A1 (0.33) | L3MBTL1KDM4EALDH1A1HPGDLMNA | |
| SCHEMBL22946001 | 0.87 | POLB (0.30) | POLB | |
| SCHEMBL22945602 | 0.87 | L3MBTL1 (0.34) | L3MBTL1KDM4EALDH1A1HPGDLMNA | |
| SCHEMBL22945603 | 0.87 | L3MBTL1 (0.34) | L3MBTL1KDM4EALDH1A1HPGDLMNA | |
| SCHEMBL21515296 | 0.87 | L3MBTL1 (0.32) | L3MBTL1KDM4EALDH1A1HPGDLMNA | |
| SCHEMBL22945980 | 0.86 | TDP1 (0.35) | L3MBTL1KDM4EALDH1A1HPGDTDP1 | |
| SCHEMBL22946126 | 0.86 | CREBBP (0.31) | L3MBTL1KDM4EALDH1A1LMNATDP1 | |
| SCHEMBL22945610 | 0.85 | CYP1A2 (0.36) | L3MBTL1TDP1CYP1A2POLB | |
| SCHEMBL22945620 | 0.85 | ALDH1A1 (0.32) | L3MBTL1KDM4EALDH1A1HPGDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | L3MBTL1 339/4885KDM4E 1857/4885ALDH1A1 271/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | L3MBTL1 339/4885KDM4E 1857/4885ALDH1A1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.